We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.12B
AUM Growth
+$146M
Cap. Flow
-$6.04M
Cap. Flow %
-0.54%
Top 10 Hldgs %
16.93%
Holding
462
New
136
Increased
57
Reduced
41
Closed
111

Sector Composition

Rank Sector Weight
1 Financials 29.94%
2 Healthcare 10.97%
3 Technology 7.15%
4 Communication Services 3.95%
5 Industrials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNTM
126
DELISTED
Pontem Corporation
PNTM
$2.91M 0.26%
299,997
BOAS
127
DELISTED
BOA Acquisition Corp.
BOAS
$2.91M 0.26%
300,000
ANAC
128
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$2.91M 0.26%
298,399
-200
-0.1% -$1.94K
EVOJ
129
DELISTED
Evo Acquisition Corp. Class A Common Stock
EVOJ
$2.91M 0.26%
300,000
NSIT icon
130
Insight Enterprises
NSIT
$3.82B
$2.87M 0.26%
+31,832
New +$3.08M
GOOGL icon
131
Alphabet (Google) Class A
GOOGL
$4.08T
$2.87M 0.26%
21,440
+19,440
+972% +$2.65M
AEON icon
132
AEON Biopharma
AEON
$11.1M
$2.83M 0.25%
4,036
-131
-3% -$91.5K
MTTRW
133
DELISTED
Matterport, Inc. Warrant
MTTRW
$2.81M 0.25%
+148,510
New +$939K
BNIXU
134
DELISTED
Bannix Acquisition Corp. Unit
BNIXU
$2.8M 0.25%
+271,471
New +$2.77M
SDST
135
Stardust Power Inc
SDST
$12.8M
$2.78M 0.25%
28,670
-1,330
-4% -$129K
QDRO
136
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$2.76M 0.25%
283,500
-16,500
-6% -$160K
ANEB
137
DELISTED
Anebulo Pharmaceuticals
ANEB
$2.73M 0.24%
416,546
-11,954
-3% -$83.8K
GGGVU
138
DELISTED
G3 VRM Acquisition Corp. Units
GGGVU
$2.71M 0.24%
+265,800
New +$2.69M
FTAA
139
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
$2.69M 0.24%
+272,506
New +$2.69M
DNZ
140
DELISTED
D and Z Media Acquisition Corp.
DNZ
$2.63M 0.24%
270,779
AKIC
141
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
$2.58M 0.23%
264,663
MEOAU
142
DELISTED
Minority Equality Opportunities Acquisition Inc. Units
MEOAU
$2.57M 0.23%
+250,000
New +$2.53M
TBCP
143
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$2.54M 0.23%
259,980
KBR icon
144
KBR
KBR
$4.58B
$2.52M 0.23%
63,827
CENQU
145
DELISTED
CENAQ Energy Corp. Unit
CENQU
$2.51M 0.22%
+250,000
New +$2.49M
OSTRW
146
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$2.51M 0.22%
257,586
-125,114
-33% -$76.5K
EQHA
147
DELISTED
EQ Health Acquisition Corp.
EQHA
$2.49M 0.22%
254,900
BNAI
148
Brand Engagement Network
BNAI
$77.9M
$2.44M 0.22%
25,000
CLRM
149
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
$2.44M 0.22%
249,999
COVA
150
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
$2.44M 0.22%
250,000

Similar funds

Mangrove Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Mangrove Partners held 462 positions worth $1.12B, up 15% from $971M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Mangrove Partners's Q3 2021 filing shows 136 new, 57 increased, 41 reduced and 111 closed positions. Its largest new stake was Biogen: 45,872 shares worth $13M. The largest sale was Macquarie Infrastructure Holdings, LLC, an estimated $32.2M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 37% a quarter earlier, followed by Healthcare and Technology.

  • Mangrove Partners's largest Q3 2021 buy was Biogen: 45,872 shares worth $13M.
  • Mangrove Partners added most to Travere Therapeutics in Q3 2021, an estimated $6.57M increase.
  • Mangrove Partners's biggest Q3 2021 reduction was Pershing Square Tontine Holdings, Ltd., cutting an estimated $12.8M.
  • Mangrove Partners fully exited Macquarie Infrastructure Holdings, LLC in Q3 2021, selling an estimated $32.2M.
  • Mangrove Partners's ten largest holdings make up 17% of its $1.12B portfolio in Q3 2021.
  • Mangrove Partners opened 136 new positions and closed 111 in Q3 2021.
  • Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $1.12B.

Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.